Supreme Court turns down Mar­tin Shkre­li's lat­est ap­peal, leav­ing 'phar­ma bro' to 7-year sen­tence

Mar­tin Shkre­li will con­tin­ue to serve out his sen­tence af­ter the lat­est ap­peal to over­turn his con­vic­tion was re­ject­ed by the Supreme Court.

Bet­ter known out­side biotech cir­cles as “phar­ma bro,” Shkre­li was sen­tenced to sev­en years in fed­er­al prison on three felony fraud con­vic­tions re­lat­ing to two hedge funds and one biotech, Retrophin, he found­ed. The Supreme Court jus­tices re­fused to hear his ap­peal, which would have al­so in­volved a $7.36 mil­lion for­fei­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER